RT Journal Article
SR Electronic
T1 Captopril renography for the detection of renovascular hypertension
JF Cleveland Clinic Journal of Medicine
JO Cleve Clin J Med
FD Cleveland Clinic
SP 311
OP 318
VO 55
IS 4
A1 Joseph V. Nally, Jr.
A1 Bharat K. Gupta
A1 Harry S. Clarke, Jr.
A1 James T. Higgins, Jr.
A1 William J. Potvin
A1 Michael L. Gross
YR 1988
UL http://www.ccjm.org/content/55/4/311.abstract
AB The effect of a provocative challenge with an angiotensin-converting enzyme inhibitor (captopril) upon technetium-99m-labeled diethylene triaminepentaacetic acid (Tc-99m-labeled DTPA) and iodohippurate sodium 1-131 (1-131 Hippuran) renograms was studied in a group of 16 selected hypertensive patients. The patients were categorized as having either renal artery stenosis (RAS, n= 11) or essential hypertension (EHT, n=5) based upon renal angiographic findings. In patients with RAS, captopril altered the time-activity curves of the stenotic kidney(s) of both radionuclide studies and improved the diagnostic sensitivity. In patients with EHT, captopril did not alter the radionuclide studies. Converting-enzyme inhibition coupled with noninvasive radionuclide studies of the renovascular bed offers promise in improving the sensitivity and specificity for detecting hemodynamically significant RAS in the hypertensive population.